Come up with a name for your new list and we'll add to it:
Medicenna Therapeutics was acquired by
A2 Acquisition Corp on February 06, 2017.
Medicenna Therapeautics is a clinical stage, privately held, immuno-oncology company developing Interleukin-4 Empowered Cytokines (IL4-ECs) that specifically target the Interleukin-4 Receptor (IL4R). …